BioSyent Inc.

OTCPK:BIOY.F Stock Report

Market Cap: US$127.9m

BioSyent Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:BIOY.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
30 Mar 26SellUS$1,056Peter LockhardIndividual100US$10.56
30 Mar 26SellUS$3,799Ramesh MoothanIndividual370US$10.27
26 Mar 26SellUS$2,127Peter LockhardIndividual200US$10.65
23 May 25SellUS$3,144Peter LockhardIndividual363US$8.68
22 May 25SellUS$1,694Peter LockhardIndividual200US$8.47

Insider Trading Volume

Insider Buying: BIOY.F insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of BIOY.F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,087,7619.37%
Individual Insiders1,291,36711.1%
Institutions2,219,44119.1%
General Public7,016,12060.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 19 shareholders own 39.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.37%
1069867 Ontario Ltd
1,087,761US$12.0m0%no data
9.32%
FAX Capital Corp.
1,082,790US$11.9m0%96.23%
6.38%
René Goehrum
741,002US$8.2m0%no data
4.3%
Intrepid Equity Finance Ltd.
500,000US$5.5m0%no data
2.22%
Grandeur Peak Global Advisors, LLC
257,652US$2.8m21%0.09%
1.72%
Van Berkom and Associates Inc.
200,172US$2.2m0%0.06%
1.57%
Peter Lockhard
182,709US$2.0m0.4%no data
1.54%
Canadian Western Trust Company
178,827US$2.0m-17.4%100.0%
0.56%
Robert March
64,519US$710.2k4.76%no data
0.53%
Kevin Wilson
61,058US$672.1k3.23%no data
0.52%
Joost van der Mark
60,644US$667.6k4.39%no data
0.42%
Seyed Ashrafi
49,048US$539.9k0.31%no data
0.29%
Sharan Raghubir
34,083US$375.2k-5.44%no data
0.2%
Neelu Atwal
23,582US$259.6k1.57%no data
0.18%
Ramesh Moothan
21,065US$231.9k2.85%no data
0.14%
Sara Elford
16,379US$180.3k2.14%no data
0.14%
Marnie Mccormick
15,827US$174.2k0%no data
0.12%
Joseph Arcuri
14,016US$154.3k3.39%no data
0.064%
Stephen Wilton
7,435US$81.8k38.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/21 22:32
End of Day Share Price 2026/04/21 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioSyent Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Tania Armstrong-WhitworthATB Cormark Historical (Cormark Securities)
David MartinBloom Burton & Co.
Scott CurtisCantor Fitzgerald Canada Corporation